From April 1, 2023 to May 23, 2023, the company has repurchased 3,352,200 shares, representing 0.51% for CNY 46.93 million. With this, the company has completed the repurchase of 5,937,000 shares, representing 0.91% for CNY 100 million under the buyback announced on October 26, 2022.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 CNY | -0.22% |
|
-2.54% | -50.75% |
27/06 | Guangdong Hybribio Biotech Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. | CI |
27/06 | Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.75% | 41Cr | |
-11.78% | 1.14TCr | |
-13.76% | 739.82Cr | |
+29.50% | 563.58Cr | |
-0.19% | 533.25Cr | |
-19.19% | 370.26Cr | |
+7.62% | 257.78Cr | |
-65.24% | 237.62Cr | |
-10.48% | 220.46Cr | |
+27.80% | 220.02Cr |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on October 26, 2022.